在AD中,NRN1可能通过PIGU-CASP3轴调节TAU酸化和神经细胞亡
Wenshuo Cheng1, Jia Zhang1,2, Hui Zhu3
1The Key Laboratory of Xinjiang Endemic and Ethnic Diseases and Department of Biochemistry, Shihezi University School of Medicine, Shihezi, 832003, China.
Current Alzheimer research
|April 29, 2025
概括
神经1 (NRN1) 可能通过调节PIGU-CASP3通路来降低阿尔茨海默病 (AD) 中的陶蛋白酸化和神经元亡. 这表明NRN1是AD治疗的潜在治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特征是蛋白过酸化和粉样β沉积.
- 阿尔茨海默病的确切调节机制尚不清楚,尽管神经营养因子 (NTF) 显示出治疗潜力.
- NTF对于神经元的发育,分化和生存至关重要.
研究的目的:
- 为了研究NTFs对AD中蛋白酸化的影响.
- 阐明NTF在AD作用的潜在分子机制.
- 探索NRN1作为AD的潜在治疗剂.
主要方法:
- 生物信息学分析将NTF与陶酸化基因相关联.
- 在体内和体外研究验证了NRN1对陶酸化和亡的影响.
- 基因本体学 (GO),KEGG通路和蛋白质-蛋白质相互作用 (PPI) 网络分析确定了关键的调节因素和通路.
- 西部斑点分析检查了NRN1对陶酸化的作用机制.
主要成果:
- NRN1与TAU酸化基因MAPT呈现显著的负相关性.
- 在AD小鼠中,海马体中NRN1降低和p-tau增加.
- 在AD细胞模型中,NRN1降低了p-tau和增加了MAP2表达.
- NRN1降低了分裂的caspase-3并增加了Bcl-2/Bax比率,表明细胞亡减少.
- 确定了PIGU和CASP3作为NRN1调节陶酸化的关键调节剂.
结论:
- 通过PIGU-CASP3通路,NRN1可以缓解AD中的陶酸化和神经元亡.
- NRN1为阿尔茨海默病提供了一个新的治疗点.
- 这些发现为AD病原和潜在的治疗策略提供了新的见解.
相关概念视频
Enzyme-linked Receptors
64.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.7K
Regulation of the Unfolded Protein Response
2.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K


